Actualités

Elf Beauty Chief Executive Officer Tarang Amin says the company is excited about expanding into hair care products. It launched a new partnership with Target in June. Amin talks about that and the latest earnings report on "Bloomberg The Close."

Bending Spoons stock offers a high-profile lesson in how to handle liquidity in initial public offerings — a lesson that is set to come due for other recent IPOs like Space Exploration Technologies stock. Investor Greg Morton tells Investor's Business Daily's "Investing with IBD" podcast that it's not about trading every IPO that appears, but finding the best of the best that pass his filters for profitability and liquidity. "Two thirds of (IPOs) I'm hardly even looking at, and then they need to be liquid — that cuts it in half again," Morton said.

Michael Reinking, Senior Market Strategist at the NYSE, reviews a pivotal week in which the S&P 500 broke above its May-July trading range near 7,600, driven by strong Q2 earnings, easing oil prices, and mispositioning in tech that sparked a broad-based rally. Hyperscalers led the charge as investors embraced the ongoing shortage of compute capacity, while semiconductors and optical stocks saw volatile swings amid eye-popping growth figures and sky-high expectations. Looking ahead, Friday's jobs report and next week's inflation prints take center stage, with reports suggesting Fed Chair Warsh could support a September rate hike should the data come in hot.

Uber Technologies Inc (NYSE:UBER, XETRA:UT8) saw its price target lowered to $101 from $103 by Bank of America, which maintained a ‘Buy’ rating following the company’s second quarter results, with the analysts citing a lower valuation multiple despite raising their earnings estimates. Shares...

The central bank has let the bond market do its heavy lifting when it comes to rates. But a cut is on the horizon if a weak jobs and inflation stir up Wall Street.

Fiserv navigates near-term headwinds with a focus on long-term growth, technology investments, and a comprehensive portfolio review under new leadership.

Deutsche Telekom AG (DTEGF) raises free cash flow guidance and proposes a EUR3 billion buyback, driving adjusted EPS up 10.3%.

Albemarle Corp (ALB) reports a 31% sales surge and doubled adjusted EBITDA, but navigates CGP3 fire impacts and volatile lithium pricing.

Himax Technologies Inc (HIMX) exceeds Q2 2026 guidance with robust automotive and non-driver sales, while navigating supply chain constraints and setting a positive Q3 outlook.

Alani Nu's 56% retail surge and Rockstar integration offset a 12% decline in Brand Celsius sales, as management navigates SKU rationalization and sets sights on a Q4 recovery.

Roivant said its first quarter was relatively quiet operationally but positioned the company for a more active second half of 2026, with a potential launch of brepocitinib in dermatomyositis, multiple clinical readouts and further updates from Immunovant (NASDAQ:IMVT). Chief Executive Officer Matt

Himax Technologies (NASDAQ:HIMX) reported second-quarter 2026 results that exceeded its prior guidance, as stronger-than-expected automotive integrated-circuit sales lifted revenue, gross margin and profit. Revenue for the quarter totaled $227.4 million, up 14.2% sequentially and 5.9% from a year e

Warner Bros. Discovery Inc (WBD) posts record streaming revenue and robust subscriber growth, while navigating linear ad declines and a lighter film slate.

NexGen Energy Ltd (NXE) advances Rook One construction on schedule while securing strategic uranium contracts and exploring accretive financing options.

Regenxbio advances RGX-202 and RGX-121 programs while securing $208 million in new funding to support operations through late 2027.

Roivant Sciences Ltd (ROIV) reports robust financials and key clinical milestones, including the brepocitinib launch and Moderna settlement, while navigating pipeline uncertainties.

Oscar Health Inc (OSCR) delivers a stellar Q2 with revenue up 70% and net income of $362 million, prompting a $250 million increase to full-year earnings guidance.

Chipotle Mexican Grill shares extended their decline after the CDC linked a multistate Salmonella outbreak to jalapeño peppers served at the chain and other Mexican-style restaurants.

Palladyne AI Corp (PDYN) reports a 470% year-over-year revenue surge, driven by strong backlog growth and a major partnership with IAI for loitering munitions.

Quantinuum's first post-IPO earnings could reveal commercialization progress, bookings and spending trends as investors gauge execution in quantum computing.

DraftKings Inc. (NASDAQ:DKNG) reports second-quarter earnings after the bell today, with the call scheduled for Friday morning. Polymarket gives DraftKings just a 52% chance of beating expectations. What words will be spoken on the call trade on Kalshi, where the...

The company is known as one of the most reliable dividend payers in the stock market.

The FDA approved the first drug to treat a root cause of narcolepsy, which could help other sleep conditions as well.

Shopify shares gapped nearly 18% higher Wednesday

(Bloomberg) -- Nscale is telling prospective investors it has about $51 billion of total contracted revenue ahead of a US initial public offering that could take place as soon as in September, according to people familiar with the matter.Most Read from BloombergIran Says Agreement on Hormuz Shipping Reached With OmanGoogle AI Veterans Depart During Seismic Leadership ShiftWhy Do Data Centers Use So Much Fresh Water?Microsoft’s AI Sales Mostly Come From OpenAI, Disclosures ShowOpenAI Models Joine

As SpaceX stock has tumbled since its record-setting IPO, shares of newly public smaller companies have soared.

FOX (NASDAQ:FOX) reported record fiscal 2026 revenue and EBITDA, as the company benefited from FIFA Men’s World Cup advertising, growth at Tubi and FOX One, and continued strength in its news and sports businesses. For the fiscal year ended 2026, revenue increased 5% to more than $17 billion, while

Fluence Energy (NASDAQ:FLNC) reported record third-quarter order intake and backlog growth, including its first signed data-center developer order, while lowering its fiscal 2026 revenue and adjusted EBITDA outlook because of delays ramping new manufacturing capacity. President and Chief Executive

📣 “We have every expectation the transaction will close.” —Warner Bros. Discovery CEO David Zaslav, speaking to analysts today about Paramount's agreement to buy the company, which has faced legal challenges of late.

Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!